Ftse Mib
33.935,56
0,16%
DAX
18.937,28
-0,27%
S&P 500
5.732,93
0,25%
NASDAQ
18.074,52
0,00%
Bitcoin
63.821,99
-0,69%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PureTech Health PLC (PRTC) PureTech Health PLC (PRTC) Notizie

PureTech Health PLC

PRTC
20,46
0,98 (5,03%)
Pre Mercato
Ultimo aggiornamento: 14:04:10
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/9/202408:00BWPureTech Founded Entity Vor Bio Announces New Clinical Data..
28/8/202422:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202413:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202408:01BWPureTech Health plc – Half-Year Report
22/8/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/8/202408:00BWPureTech Appoints Michele Holcomb, PhD, to Board of..
21/8/202408:00BWPureTech Health: Notice of Half-Yearly Results
13/8/202413:05BWPureTech Founded Entity Seaport Therapeutics Appoints David..
23/7/202414:26BWPureTech Founded Entity Vedanta Biosciences Expands..
24/6/202418:00BWPureTech Health: Completion of Tender Offer & Total Voting..
24/6/202408:00BWPureTech Health: Results of the Tender Offer
20/6/202408:00BWPureTech Announces Change of Board Role
18/6/202413:05BWPureTech Founded Entity Seaport Therapeutics Appoints..
13/6/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/6/202419:15BWPureTech Health: Results of Annual General Meeting
06/6/202422:39EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
06/6/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202418:38BWPureTech Health: Result of General Meeting
04/6/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202413:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
30/5/202414:05EDGAR2Form SC 13D/A - General statement of acquisition of..
29/5/202422:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202414:09BWPureTech Founded Entity Akili Interactive and Virtual..
23/5/202413:00BWPureTech to Present at the Jefferies Global Healthcare..
21/5/202413:05BWPureTech Founded Entity Vedanta Biosciences Enrolls First..
20/5/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/5/202413:03EDGAR2Form SC TO-I - Tender offer statement by Issuer
20/5/202408:00BWPureTech Health: Launch of Proposed $100 Million Tender..
09/5/202413:05BWPureTech Founded Entity Seaport Therapeutics Presents Data..
07/5/202413:05BWPureTech Founded Entity Seaport Therapeutics Adds Industry..
25/4/202411:22BWPureTech Announces Annual Results for Year Ended December..
18/4/202408:00BWPureTech Health: Notice of Results
16/4/202413:00BWPureTech Announces Completion of Enrollment in Phase 2b..
11/4/202413:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
09/4/202408:00BWPureTech Launches Seaport Therapeutics with $100 Million..
19/3/202408:00BWPureTech Proposes $100 Million Capital Return
18/3/202414:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
13/3/202412:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
27/2/202413:00BWPureTech to Present at Two Upcoming Investor Conferences
27/2/202408:00BWPureTech Founded Entity Akili Announces Positive Results..
04/1/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202413:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
22/12/202315:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
20/12/202308:00BWPureTech Year End Update and Outlook for 2024
07/12/202312:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
29/11/202316:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
17/11/202308:00BWPureTech Founded Entity Karuna Therapeutics Announces..
14/11/202308:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
02/11/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202308:00BWPureTech to Present at Two Upcoming Investor Conferences
Apertura: Min: Max:
Chiusura: 19,48

La tua Cronologia

NASDAQ
PRTC
PureTech Health
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network